Charisse R. Lillie's Insider Trades & SAST Disclosures

Charisse R. Lillie's most recent trade in Exelon Corp. was a trade of 3,720 2026 Directors Restricted Stock Units done . Disclosure was reported to the exchange on April 28, 2026.

Share

Note

This is a custom search result for pattern Charisse R. Lillie.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Exelon Results Board Meeting	Charisse R. Lillie	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2026	3,720	3,720	-		-	2026 Directors Restricted Stock Units
Exelon Results Board Meeting	Charisse R. Lillie	Director	Grant, award, or other acquisition of securities at price $ 49.82 per share.	31 Mar 2026	878	12,554	-	49.8	43,742	Common stock- deferred stock units
Exelon Results Board Meeting	Charisse R. Lillie	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2026	5	3,855	-		-	Deferred phantom share equivalents
Exelon Results Board Meeting	Charisse R. Lillie	Director	Grant, award, or other acquisition of securities at price $ 43.87 per share.	31 Dec 2025	940	11,579	-	43.9	41,238	Common stock- deferred stock units
Exelon Results Board Meeting	Charisse R. Lillie	Director	Grant, award, or other acquisition of securities at price $ 43.43 per share.	30 Sep 2025	950	10,542	-	43.4	41,259	Common stock- deferred stock units
Exelon Results Board Meeting	Charisse R. Lillie	Director	Grant, award, or other acquisition of securities at price $ 43.25 per share.	30 Jun 2025	954	9,505	-	43.3	41,261	Common stock- deferred stock units
Exelon Results Board Meeting	Charisse R. Lillie	Director	Grant, award, or other acquisition of securities at price $ 44.19 per share.	31 Mar 2025	933	8,473	-	44.2	41,229	Common stock- deferred stock units
Exelon Results Board Meeting	Charisse R. Lillie	Director	Grant, award, or other acquisition of securities at price $ 36.87 per share.	31 Dec 2024	1,119	7,472	-	36.9	41,258	Common stock- deferred stock units
Exelon Results Board Meeting	Charisse R. Lillie	Director	Grant, award, or other acquisition of securities at price $ 40.23 per share.	30 Sep 2024	1,025	6,288	-	40.2	41,236	Common stock- deferred stock units
Exelon Results Board Meeting	Charisse R. Lillie	Director	Grant, award, or other acquisition of securities at price $ 35.54 per share.	30 Jun 2024	1,161	5,213	-	35.5	41,262	Common stock- deferred stock units
Exelon Results Board Meeting	Charisse R. Lillie	Director	Grant, award, or other acquisition of securities at price $ 36.48 per share.	31 Mar 2024	1,131	4,010	-	36.5	41,259	Common stock- deferred stock units
Exelon Results Board Meeting	R. Charisse Lillie	Director	Grant, award, or other acquisition of securities at price $ 39.21 per share.	31 Dec 2023	1,052	2,849	-	39.2	41,249	Common stock- deferred stock units
Exelon Results Board Meeting	Charisse R. Lillie	Director	Grant, award, or other acquisition of securities at price $ 40.08 per share.	30 Jun 2023	758	758 (0%)	0%	40.1	30,381	Common Stock (Deferred Stock Units)
Exelon Results Board Meeting	Charisse R. Lillie	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2023	25	3,483	-		-	Deferred Compensation - Phantom Share Equivalents

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades